Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Abiraterone-d4 | 2122245-62-7 | 98.0% | C24H27D4NO | 1 MG
SDP

Catalog No. 5000433928
Encompass_Preferred

Abiraterone-d4 is a deuterium-labeled version of Abiraterone, acting as a potent, irreversible inhibitor of CYP17A1. It exhibits antiandrogen activity by inhibiting 17α-hydroxylase and 17,20-lyase activities of CYP17 (IC50 values of 2.5 nM and 15 nM, respectively). Intended for research use only, it serves as a tracer or internal standard for quantitative analysis methods like NMR, GC-MS, or LC-MS. Deuteration aids quantitation in drug development and can influence pharmacokinetic and metabolic profiles.

  • Potent, irreversible CYP17A1 inhibitor
  • Antiandrogen activity, inhibiting 17α-hydroxylase and 17,20-lyase activities of CYP17
  • For research use only
  • Tracer or internal standard for quantitative analysis (NMR, GC-MS, LC-MS)
  • Deuteration for quantitation in drug development and influencing pharmacokinetic profiles

Catalog No. 50-004-33928 Supplier Medchemexpress LLC Supplier No. HY70013S1MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Abiraterone-d4 is a deuterium-labeled version of Abiraterone, acting as a potent, irreversible inhibitor of CYP17A1. It exhibits antiandrogen activity by inhibiting 17α-hydroxylase and 17,20-lyase activities of CYP17 (IC50 values of 2.5 nM and 15 nM, respectively). Intended for research use only, it serves as a tracer or internal standard for quantitative analysis methods like NMR, GC-MS, or LC-MS. Deuteration aids quantitation in drug development and can influence pharmacokinetic and metabolic profiles.

  • Potent, irreversible CYP17A1 inhibitor
  • Antiandrogen activity, inhibiting 17α-hydroxylase and 17,20-lyase activities of CYP17
  • For research use only
  • Tracer or internal standard for quantitative analysis (NMR, GC-MS, LC-MS)
  • Deuteration for quantitation in drug development and influencing pharmacokinetic profiles

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.